Sarah Yuan
Chief Technology Officer, Cabaletta Bio
Sarah Yuan is listed as Chief Technology Officer, Cabaletta Bio. Sarah is scheduled to speak at Advanced Therapies Week 2027 on 19 January 2027.
Compiled from published conference agendas; not yet confirmed by Sarah. Is this you? Claim this profile.
About
Dr. Sarah Yuan is a biopharmaceutical executive with more than 25 years of experience in technical development, manufacturing, and CMC strategy across commercial biologics and advanced cell therapies. She currently serves as Chief Technology Officer at Cabaletta Bio, where she leads Technical Development, Manufacturing, Supply Chain, and CMC Strategy. Prior to Cabaletta, Dr. Yuan served as Chief Technical Operations Officer at Sigilon Therapeutics, which was acquired by Eli Lilly in 2023, where she led CMC development for a novel cell therapy platform. Previously, as Vice President of Process and Analytical Development at bluebird bio and 2seventy bio, she played a key role in securing regulatory approvals for three cell therapy products. Earlier in her career, Dr. Yuan held leadership positions at Sanofi, Bioverativ, and Biogen, where she led CMC development, manufacturing sciences, and external manufacturing activities supporting clinical and commercial biologics, including the comme
Upcoming
Advanced Therapies Week 2027 19 January 2027 – 21 January 2027
- Session 1: Autologous and allogeneic cell therapies – what’s the latest progress in reducing process timeframes and cost of goods while enhancing scalability, quality, and consistency? Speaker · 19 January 2027
- Session 5: Stepping back and reviewing the advanced therapy sector’s approach to automation Speaker · 20 January 2027
- Spotlight: Scaling autologous CAR-T manufacturing for autoimmune patients Speaker · 20 January 2027
Spoke alongside
People who have shared a session with Sarah at events on B2DB.
- Greg Russotti Chief Technology & Manufacturing Officer · Century Therapeutics 2 shared sessions
- Dena Flamm Business Development Manager · OPTIMA packaging group GmbH 1 shared session
- Isabel Tian Senior Director, Scientific Affairs · Cellares 1 shared session
- Jeffrey Cram Vice President of Process Development · Elevatebio 1 shared session
- Jeffrey Graybill Vice President, CMC Commercial Strategy · Immatics 1 shared session
- Mamta Kalra Vice President Process and Analytical Development · Immatics 1 shared session
- Vilma Methner Senior Market Development Manager - ATMP · OPTIMA packaging group GmbH 1 shared session
- Xavier de Mollerat du Jeu Global Head of Automation · Legend Biotech 1 shared session